At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
Daiichi Sankyo’s PhD Fellowship Program offers early-career scientists a unique opportunity to launch their careers at the forefront of drug development and innovation focusing on advancing model informed drug development. The role will serve to establish PK/PD/efficacy/safety relationships in clinical settings to drive the development of potential drug candidates. This program is designed for recent PhD graduates and provides direct placement into a full-time role while offering structured development, mentorship, and visibility to leadership.
This particular PhD Fellowship will be within the TA Oncology department with a core focus on Quantitative Clinical Pharmacology.
Program Features:
Education Qualifications
Travel Requirements
Ability to travel up to 10% of the time.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Salary Range:
USD$100,960.00 - USD$151,440.00
